Related Experiment Video
Updated: Dec 17, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
The Effects of Sidt2 on the Inflammatory Pathway in Mouse Mesangial Cells
Hui Sun1,2, Jia-Ming Ding3, Hui-Hao Zheng4
1Department of Endocrinology and Genetic Metabolism, Yijishan Hospital of Wannan Medical College, Wuhu 241002, China.
Abstract:
In patients with chronic kidney disease, the abnormal activation of inflammatory pathways is usually an important factor leading to renal fibrosis and further deterioration of renal function. Finding effective intervention targets of the inflammatory signaling pathway is an important way to treat chronic kidney disease. As a newly discovered lysosomal membrane protein, the correlation between SID1 transmembrane family member 2 (Sidt2) and the inflammatory signaling pathway has not been reported. The aim of this study was to investigate the effect of Sidt2 on inflammation by inhibiting the expression of the Sidt2 gene in a mouse mesangial cell line mediated by a lentiviral CRISPR/Cas9 vector. Hematoxylin and eosin staining and microscopy found that the mesangial cells lost their normal morphology after inhibiting the expression of Sidt2, showing that the cell body became smaller, the edge between the cells was unclear, and part of the nucleus was pyknotic and fragmented, appearing blue-black. The expressions of IKK β, p-IKK α/β, NF-κB p65, p-NF-κB p65, p-IκBα, IκBα, and TNF-α in the NF-κB pathway of the Sidt2 -/- group were higher than those of the Sidt2 +/+ group. p-Jak2 and IL6 increased in the Jak/Stat pathway, and p-ERK and p-P38 increased in the MAPK pathway. The expressions of IKK β, p-IKK α/β, NF-κB p65, p-NF-κB p65, p-IκBα, IκBα, and TNF-α in the NF-κB pathway of the Sidt2 +/++LPS group were significantly higher than those in the Sidt2 +/+ group. The expressions of IKK β, p-IKK α/β, NF-κB p65, p-NF-κB p65, p-IκBα, IκBα, and TNF-α in the Sidt2 -/-+LPS group were higher than those in the Sidt2 -/- group. The expressions of p-IKK α/β, NF-κB p65, p-NF-κB p65, p-IκBα, IκBα, and TNF-α in the Sidt2 -/-+LPS group were higher than those in the Sidt2 +/++LPS group. In the Jak/Stat pathway, the protein expressions of p-Jak2 and IL6 in the Sidt2 +/++LPS group were higher than those in the Sidt2 +/+ group. The expressions of p-Jak2 and IL6 in the Sidt2 -/-+LPS group were higher than those in the Sidt2 -/- group. The expressions of p-Jak2 and IL6 in the Sidt2 -/-+LPS group were higher than those in the Sidt2 +/++LPS group. The expressions of p-JNK, p-ERK, p-P38, and ERK in the MAPK pathway in the Sidt2 +/++LPS group were higher than those in the Sidt2 +/+ group. The expressions of p-JNK, p-ERK, p-P38, and ERK in the Sidt2 -/-+LPS group were higher than those in the Sidt2 -/- group. The expressions of p-JNK, p-ERK, p-P38, and ERK in the Sidt2 -/-+LPS group were higher than those in the Sidt2 +/++LPS group. These data suggested that deletion of the Sidt2 gene changed the three inflammatory signal pathways, eventually leading to the damage of glomerular mesangial cells in mice.
Insights
Inhibition of SID1 transmembrane family member 2 (Sidt2) in mouse mesangial cells exacerbated inflammation and cell damage. Sidt2 deficiency activates key inflammatory pathways, suggesting Sidt2 plays a protective role in kidney disease.
Area of Science:
- Nephrology
- Molecular Biology
- Immunology
Background:
- Chronic kidney disease (CKD) is characterized by inflammatory pathways contributing to renal fibrosis and function decline.
- Targeting inflammatory signaling pathways is crucial for CKD treatment.
- The role of SID1 transmembrane family member 2 (Sidt2) in inflammation remains largely unexplored.
Purpose of the Study:
- To investigate the effect of Sidt2 on inflammation in mouse mesangial cells.
- To determine the role of Sidt2 in regulating inflammatory signaling pathways.
- To explore Sidt2 as a potential therapeutic target for CKD.
Main Methods:
- Utilized a lentiviral CRISPR/Cas9 vector to inhibit Sidt2 gene expression in a mouse mesangial cell line.
- Performed Hematoxylin and eosin staining and microscopy to assess cell morphology.
- Analyzed the expression levels of key proteins in the NF-κB, Jak/Stat, and MAPK inflammatory pathways.
Main Results:
- Sidt2 inhibition led to altered mesangial cell morphology, with smaller cell bodies and nuclear fragmentation.
- Deletion of Sidt2 upregulated inflammatory markers in the NF-κB, Jak/Stat, and MAPK pathways.
- LPS stimulation further amplified these inflammatory responses in Sidt2-deficient cells, indicating Sidt2's protective role.
Conclusions:
- Sidt2 deficiency significantly impacts inflammatory signaling pathways, including NF-κB, Jak/Stat, and MAPK.
- The absence of Sidt2 exacerbates inflammatory responses and contributes to glomerular mesangial cell damage.
- Sidt2 may serve as a potential therapeutic target for mitigating inflammation in CKD.
More Related Videos
08:43Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice
Published on: January 31, 2020
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024